Druid BioVentures

investment firm

Druid BioVentures is a principal investment firm specializing in investments in novel drug with a focus on virtual companies.

Number of Investments

Number of Lead Investments

Druid BioVentures has made 3 investments. Their most recent investment was on Dec 3, 2014, when Naurex raised $80M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 3, 2014 Naurex	Series C	$80M	Biopharma	—
Dec 17, 2012 Naurex	Series B	$38M	Biopharma	—
May 11, 2011 Naurex	Series A	$18M	Biopharma	—

Druid BioVentures has had 1 exits. Druid BioVentures most notable exits include Naurex

Date	Company Name	Exit Type	Industry
Jul 27, 2015	Naurex	M&A	Biopharma	Detail